HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ursolic acid enhances the therapeutic effects of oxaliplatin in colorectal cancer by inhibition of drug resistance.

Abstract
It has been reported that ursolic acid has anti-tumor activity and it enhances the therapeutic effect of oxaliplatin in colorectal cancer (CRC). However, the underlying mechanisms remain unknown. In the present study, the mechanisms of the enhancement of therapeutic effects through use of ursolic acid were investigated. We treated CRC cell lines HCT8 and SW480 with ursolic acid and oxaliplatin and monitored the effects on cell proliferation, apoptosis, reactive oxygen species (ROS) production and drug resistance gene production. We discovered that treatment with a combination of ursolic acid and oxaliplatin resulted in significant inhibition of cell proliferation, significantly increased apoptosis and ROS production, and significant inhibition of drug resistance gene expression. Our study provided evidence that ursolic acid enhances the therapeutic effects of oxaliplatin in colorectal cancer by ROS-mediated inhibition of drug resistance.
AuthorsYe Zhang, Longchang Huang, Haoze Shi, Hang Chen, Jianxin Tao, Renhui Shen, Tong Wang
JournalCancer science (Cancer Sci) Vol. 109 Issue 1 Pg. 94-102 (Jan 2018) ISSN: 1349-7006 [Electronic] England
PMID29034540 (Publication Type: Journal Article)
Copyright© 2017 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association.
Chemical References
  • Organoplatinum Compounds
  • Reactive Oxygen Species
  • Triterpenes
  • Oxaliplatin
Topics
  • Animals
  • Antineoplastic Combined Chemotherapy Protocols (administration & dosage, pharmacology)
  • Cell Line, Tumor
  • Cell Proliferation (drug effects)
  • Cell Survival (drug effects)
  • Colorectal Neoplasms (drug therapy, metabolism)
  • Drug Resistance, Neoplasm (genetics)
  • Drug Synergism
  • Humans
  • Mice
  • Organoplatinum Compounds (administration & dosage, pharmacology)
  • Oxaliplatin
  • Reactive Oxygen Species (metabolism)
  • Treatment Outcome
  • Triterpenes (administration & dosage, pharmacology)
  • Xenograft Model Antitumor Assays
  • Ursolic Acid

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: